CSPC PHARMA (01093) announced that on January 23, 2026, the company, under its Restricted Share Award Scheme, granted a total of 46.4625 million restricted shares (Award Shares) to 727 selected employees (grantees) of the group for no consideration. The grant is conditional upon acceptance by the grantees and the fulfillment of certain vesting conditions and performance targets.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.